ARYX – I don’t think much of the company’s anticoagulant, which is merely an enhanced version of warfarin. I’ve posted about this drug on a number of occasions. I don't have any opinion on the drug for AF.
I like aryx more for the AF and Propulsid look a likes, and the fact that they can seem to use their platform to make numerous more drugs that have blockbuster potential
To buy the stock here you have to really believe this enhanced warfarin will beat warfarin in the current trial. This is the drug I have my most doubts about.
If this trial fails then you buy the stock with both hands because the AF drug will garner good partnership terms in my opinion.
Market Data 
Markets 
AI
